Communication During Hospitalization About Resuscitation Trial

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2023

Study Completion Date

December 31, 2025

Conditions
Severe Life-limiting COPDSevere Life-limiting Heart FailureSevere Life-limiting CirrhosisSevere Life-limiting MalignancySevere Functional ImpairmentEnd Stage Renal Disease
Interventions
BEHAVIORAL

Informed Assent Discussion

"Participants randomized to the intervention arm will participate in a discussion about CPR with a study doctor that follows these steps:~1. Patient's values and preferences for therapies and outcomes elicited from patient and family; overall therapeutic goals formulated~2. Description of CPR and dying process provided~3. Personalized explanation provided about probable lack of achieving any reasonable therapeutic goal with CPR (i.e. why s/he is a poor candidate for CPR due to underlying illness)~4. Patient and family informed that due to severe underlying illness and high likelihood that CPR will be burdensome/harmful and will not provide benefit, CPR will not be offered unless they disagree (except in rare circumstance where overall therapeutic goals from step 1 are to preserve life regardless of quality of that life) Assessment of patient's and family's understanding of issues discussed; patients may actively disagree and request CPR be performed, but CPR not explicitly offered"

BEHAVIORAL

Usual Care with Attention Control

Participants who are randomized to the usual care arm will receive a friendly visit in the hospital from research personnel to ask if they have any questions or concerns. Follow up assessments and time windows will be explained. Importance of their participation in the study will be emphasized.

Trial Locations (4)

27599

University of North Carolina, Chapel Hill

29425

Medical University of South Carolina, Charleston

98104

University of Washington, Seattle

05405

University of Vermont, Burlington

All Listed Sponsors
collaborator

University of Washington

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

University of North Carolina, Chapel Hill

OTHER

lead

University of Vermont

OTHER

NCT02984124 - Communication During Hospitalization About Resuscitation Trial | Biotech Hunter | Biotech Hunter